换一批Endostatin sensitizes p53-deficient non-small-cell lung cancer to genotoxic chemotherapy by targeting DNA-dependent protein kinase catalytic subunit.
第一作者：
Lin,Jia
第一单位：
The National Engineering Laboratory for Anti-Tumour Protein Therapeutics, Tsinghua University, Beijing, PR China.;Beijing Key Laboratory for Protein Therapeutics, Tsinghua University, Beijing, PR China.;Cancer Biology Laboratory, School of Life Sciences, Tsinghua University, Beijing, PR China.
作者：
医学主题词
动物(Animals);抗肿瘤药(Antineoplastic Agents);细胞凋亡(Apoptosis);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);细胞系, 肿瘤(Cell Line, Tumor);DNA活化蛋白激酶(DNA-Activated Protein Kinase);内皮抑素类(Endostatins);人类(Humans);肺肿瘤(Lung Neoplasms);小鼠, 裸(Mice, Nude);肿瘤移植(Neoplasm Transplantation);肿瘤抑制蛋白质p53(Tumor Suppressor Protein p53)
DOI
10.1002/path.4952
PMID
28771739
发布时间
2019-01-29
- 浏览82
The Journal of pathology
255-266页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
